The store will not work correctly when cookies are disabled.
1-(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)propane-1,2-dione
ID: ALA4740507
PubChem CID: 145865993
Max Phase: Preclinical
Molecular Formula: C20H20Cl2N2O2
Molecular Weight: 391.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)C(=O)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C20H20Cl2N2O2/c1-14(25)20(26)24-12-10-23(11-13-24)19(15-2-6-17(21)7-3-15)16-4-8-18(22)9-5-16/h2-9,19H,10-13H2,1H3
Standard InChI Key: QAJGXQUEUPPMPH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.0186 -3.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6082 -3.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6082 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0204 -2.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6107 -1.8419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7848 -1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3703 -2.5614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7866 -3.2731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7840 -4.6964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3695 -5.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7842 -6.1267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6134 -6.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0200 -5.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3692 -1.1269 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.3705 -6.8381 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
17.8436 -3.9842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2582 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2582 -3.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0832 -3.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4936 -3.9842 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3186 -3.9842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0832 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7333 -3.2691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7333 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3186 -5.4142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5583 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 2 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 391.30 | Molecular Weight (Monoisotopic): 390.0902 | AlogP: 3.82 | #Rotatable Bonds: 4 |
Polar Surface Area: 40.62 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.77 | CX LogP: 4.27 | CX LogD: 4.27 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.74 | Np Likeness Score: -1.05 |
References
1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142] [10.1016/j.bmcl.2020.127538] |